Literature DB >> 16623981

Synchronous bilateral tonsillar carcinoma: role of fluoro-deoxyglucose positron emission tomography scanning in detecting occult primary tumours in metastatic nodal disease of the head and neck.

T Price1, J Pickles.   

Abstract

We present the second case of primary synchronous bilateral tonsillar squamous cell carcinoma reported in the English literature and evaluate the role of fluoro-deoxyglucose positron emission tomography scanning in the search for the occult primary tumour in a patient presenting with metastatic nodal disease in the head and neck.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16623981     DOI: 10.1017/S0022215106000260

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  5 in total

1.  Can diffusion-weighted imaging distinguish between normal and squamous cell carcinoma of the palatine tonsil?

Authors:  K S S Bhatia; A D King; D K W Yeung; F Mo; A C Vlantis; K-H Yu; J K T Wong; A T Ahuja
Journal:  Br J Radiol       Date:  2010-07-20       Impact factor: 3.039

Review 2.  Bilateral synchronous tonsillar carcinoma: a case series and review of the literature.

Authors:  Daniel Moualed; A Qayyum; T Price; A Sharma; S Mahendran
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-04-03       Impact factor: 2.503

3.  Squamous cell carcinoma of the tonsillar remnant--clinical presentation and oncological outcome.

Authors:  Christopher J Skilbeck; Jean-Pierre Jeannon; Mary O'Connell; Peter R Morgan; Ricard Simo
Journal:  Head Neck Oncol       Date:  2011-01-19

4.  Diagnosis of Bilateral Tonsil Cancers via Staging PET/CT: Case Report and Review.

Authors:  Edward M Mannina; Sunanda M Pejavar; Christine M Glastonbury; Annemieke van Zante; Steven J Wang; Sue S Yom
Journal:  Int J Otolaryngol       Date:  2011-07-14

Review 5.  Synchronous bilateral tonsil carcinoma: case presentation and review of the literature.

Authors:  M-N Theodoraki; J A Veit; T K Hoffmann; J Greve
Journal:  Infect Agent Cancer       Date:  2017-06-26       Impact factor: 2.965

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.